Pharmatest specialises in preclinical lead validation and efficacy research for the pharmaceutical industry. The company’s service selection includes various translational disease models for preclinical validation of new drug candidates on such indications as metastastatic cancer, osteoporosis and osteoarthritis.

The US represents a key market for Pharmatest, and by opening an office in Stamford, Connecticut, Pharmatest hopes to establish a stronger presence close to its existing and potential new customers in the US.